Abstract
The primary clinical applications of positron emission tomography (PET) myocardial perfusion imaging are to diagnose, localize, and quantify the severity of coronary artery stenoses. As a result, most clinical applications of myocardial perfusion imaging are performed in conjunction with stress testing. Exercise stress testing with single photon emission computed tomography (SPECT) is widely used in the evaluation of patients with known or suspected coronary artery disease.1–3 Although exercise stress testing offers several advantages, the short physical half-life of most PET radiotracers makes it logistically impractical for use in conjunction with PET imaging. In addition, a significant proportion of patients referred for stress imaging are unable to exercise adequately due to difficulties with ambulation related to prior stroke, peripheral vascular disease, orthopedic problems or deconditioning.3 Submaximal exercise can reduce test sensitivity for detection of ischemic heart disease and should be avoided. Pharmacologic stress testing with dipyridamole,4,5 adenosine4,6,7 or dobutamine infusions8–9 are useful to evaluate patients that are unable to exercise or have suboptimal exercise capicity.3 Chapter 9 provides a detailed discussion of stress protocols. The aim of this chapter is to provide a review of clinically useful imaging protocols for evaluation of CAD, along with guidelines for quality control of PET and PET/CT images. For a better understanding of protocols for PET myocardial perfusion imaging, the reader should be familiar with basic principles of PET and PET/CT (discussed in Chapters 1 and 3) and PET radiopharmaceuticals (discussed in Chapter 5).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ritchie JL, Trobaugh GB, Hamilton GW, et al. Myocardial imaging with thallium-201 at rest and during exercise. Comparison with coronary arteriography and resting and stress electrocardiography. Circulation. 1977;56:66–71.
Kotler TS, Diamond GA. Exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. Ann Intern Med. 1990;113:684–702.
Tadamura E, Iida H, Matsumoto K, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Amer Coll Cardiol. 2001;37:130–136.
Uren NG, Camici PG, Melin JA, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med. 1995;36:2032–2036.
Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol. 1998;32:147–153.
Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23:384–389.
Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med. 1999;40:1848–1856.
Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol. 1993;71:1351–1356.
Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol. 1993;21:1583–1590.
Beanlands RS, Muzik O, Melon P, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol. 1995;26:1465–1475.
Lurie AJ, Salel AF, Berman DS, DeNardo GL, Hurley EJ, Mason DT. Determination of improved myocardial perfusion after aortocoronary bypass surgery by exercise rubidium-81 scintigraphy. Circulation. 1976;54:III20–III23.
Chow BJ, Ananthasubramaniam K, dekemp RA, Dalipaj MM, Beanlands RS, Ruddy TD. Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography. J Am Coll Cardiol. 2005;45: 1227–1234.
Krivokapich J, Smith GT, Huang SC, et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation. 1989;80:1328–1337.
Wyss CA, Koepfli P, Mikolajczyk K, Burger C, von Schulthess GK, Kaufmann PA. Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. J Nucl Med. 2003;44:146–154.
Dorbala S, Limaye A, Crugnale S, Yang D, Fitzgerald J, Di Carli MF. Optimal timing of transmission map for rubidium 82 stress positron emission tomography (PET/CT) myocardial perfusion imaging. J Nucl Med. 2005;46:266p.
Joseph PM, Spital RD. The effects of scatter in x-ray computed tomography. Med Phys. 1982;9:464–472.
DiFilippo FP, Brunken RC. Do implanted pacemaker leads and ICD leads cause metalrelated artifact in cardiac PET/CT? J Nucl Med. 2005;46:436–443.
Nehmeh SA, Erdi YE, Ling CC, et al. Effect of respiratory gating on quantifying PET images of lung cancer. J Nucl Med. 2002;43:876–881.
Navare SM, Wackers FJ, Liu YH. Comparison of 16-frame and 8-frame gated SPET imaging for determination of left ventricular volumes and ejection fraction. Eur J Nucl Med Mol Imaging. 2003;30:1330–1337.
Lalush DS, Jatko MK, Segars WP. An observer study methodology for evaluating detection of motion abnormalities in gated myocardial perfusion SPECT. IEEE Trans Biomed Eng. 2005;52:480–485.
Germano G. Digital techniques for acquisition, processing, and analysis of nuclear cardiology images. In: Sandler MP, Patton JA, Wackers FJT, Gottschalk A, eds. Diagnostic Nuclear Medicine. Lippincott Williams & Wilkins; 1996:207–222.
Nichols K, Dorbala S, DePuey EG, Yao SS, Sharma A, Rozanski A. Influence of arrhythmias on gated SPECT myocardial perfusion and function quantification. J Nucl Med. 1999;40:924–934.
Knesaurek K, Machac J, Krynyckyi BR, Almeida OD. Comparison of 2-dimensional and 3-dimensional 82Rb myocardial perfusion PET imaging. J Nucl Med. 2003;44: 1350–1356.
Votaw JR, White M. Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies. J Nucl Med. 2001;42:701–706.
Bacharach SL. The new generation positron emission tomography/computed tomography scanners: implications for cardiac imaging. In: Zaret BL, Beller GA, eds. Clinical Nuclear Cardiology: State of the Art and Future Directions. 2005:141–151.
Chen EQ, MacIntyre WJ, Fouad FM, et al. Measurement of cardiac output with first-pass determination during rubidium-82 PET myocardial perfusion imaging. Eur J Nucl Med. 1996;23:993–996.
Mullani NA, Gould KL. First-pass measurements of regional blood flow with external detectors. J Nucl Med. 1983;24:577–581.
Bacharach SL, Bax JJ, Case J, et al. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol. 2003;10:543–556.
Bettinardi V, Gilardi MC, Lucignani G, et al. A procedure for patient repositioning and compensation for misalignment between transmission and emission data in PET heart studies. J Nucl Med. 1993;34:137–142.
McCord ME, Bacharach SL, Bonow RO, Dilsizian V, Cuocolo A, Freedman N. Misalignment between PET transmission and emission scans: its effect on myocardial imaging. J Nucl Med. 1992;33:1209–1214; discussion 1214–1215.
Loghin C, Sdringola S, Gould KL. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. J Nucl Med. 2004;45:1029–1039.
Mirzaei S, Guerchaft M, Bonnier C, Knoll P, Doat M, Braeutigam P. Use of segmented CT transmission map to avoid metal artifacts in PET images by a PET-CT device. BMC Nucl Med. 2005;5:3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Dorbala, S., Di Carli, M.F. (2007). PET and Integrated PET/CT Myocardial Imaging Protocols and Quality Assurance. In: Di Carli, M.F., Lipton, M.J. (eds) Cardiac PET and PET/CT Imaging. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38295-1_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-38295-1_10
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-35275-6
Online ISBN: 978-0-387-38295-1
eBook Packages: MedicineMedicine (R0)